Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthesis Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Bioanalytical Services
      • Large Molecule Services
      • Small Molecule Services
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
    • Integrated Projects
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Our Events
    • Market Activity
    • Press Events
  • Contact

Orthotopic Models

Home Service Orthotopic Models

Orthotopic cancer models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds.

Cancer Type Cell Line Luciferase Cell Line
Breast carcinoma MDA-MB-231, HCC1954, HCC70, MDA-MB-361, MCF7, HCC1954  MDA-MB-231-luc
Lung cancer NCI-H1650 A549-luc, LLC-luc
Colon carcinoma HCT-116
Glioblastoma U87-MG U87-MG-luc
Ovary carcinoma SK-OV-3
Prostate Cancer PC3
Leukemia RL, MAVER-1, Karpas299, K562, HL-60

 

Pharmacology Facility & Equipments

SPF Animal Room:

–Animal Storage: IVC System

–Combination of radiation and chemotherapy: RS 2000 Biological Research Irradiator

–In vivo tumor Imaging: IVIS Lumina III In Vivo Imaging System and Luciferase Cell Line

Services

  • Chemistry Services
  • Biology Services
  • Bioanalytical Services
  • Drug Safety Evaluation
  • Formulation Development Services
  • Pharmacology Services
  • Pharmacokinetic Services
  • Integrated Projects

Share

You May Also Like

  • Integrated Projects

    Integrated Projects

  • Drug Safety Evaluation

    Drug Safety Evaluation

  • Bioanalytical Services

    Bioanalytical Services

  • Pharmacokinetic Services

    Pharmacokinetic Services

  • Pharmacology Services

    Pharmacology Services

  • Biology Services

    Biology Services

  • Drug Formulation

    Drug Formulation

  • Chemistry Services

    chemistry

    Chemistry Services

    chemistry

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry Services
  • Biology Services
  • Bioanalytical Services
  • Drug Safety Evaluation
  • Formulation Development Services
  • Pharmacology Services
  • Pharmacokinetic Services
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.
Email: Marketing@medicilon.com.cn
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthesis Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Bioanalytical Services
      • Large Molecule Services
      • Small Molecule Services
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
    • Integrated Projects
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Our Events
    • Market Activity
    • Press Events
  • Contact
Medicilon Inc